Displaying 1 - 5 of 5
| Active Ingredient | FLUTICASONE |
| Therapeutic Class | CORTICOSTEROIDS (RESPIRATORY) |
| Indications | Asthma. |
| Caution | Headache, pharyngitis, nasal congestion, dysphonia and oral candidiasis. Rinse mouth with water after inhalation.nNot recommended for children under 1 year. |
| Dose Range | Adult and Children 4 years and over: 50-1000mcg twice daily . Pediatric 1-3 yrs: 50-100mcg twice daily. See BDS supply protocols pg. 10. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FLUTICASONE | SALMETEROL |
| Therapeutic Class | RESPIRATORY AGENTS MISCELLANEOUS |
| Indications | Asthma, chronic obstructive pulmonary disease. |
| Caution | Growth suppression, abdominal pain, dyspepsia, candidiasis, osteoporosis, back pain, cataract, glaucoma, chest congestion, hoarseness |
| Dose Range |
Asthma: Adults and Children 12 years and older: 1 inhalation twice daily (50/100, 50/250, 50/500) or 2 inhalations twice daily (25/50, 25/125, 25/250), based on asthma severity . Age 4-11: 1 Inhalation twice daily (50/100) or 2 p uffs tw |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FLUTICASONE | VILANTEROL |
| Therapeutic Class | RESPIRATORY AGENTS MISCELLANEOUS |
| Indications | Long-term maintenance of airflow obstruction in p atients with chronic obstructive pulmonary disease (COPD). |
| Caution |
Close monitoring for glaucoma and cataracts is warranted. Do not use in combination with an additional LABA because of risk of overdose. Naso-pharyngitis, upper respiratory tract infection, hea More ... |
| Dose Range | One inhalation once daily at the same time each day . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FLUTICASONE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Prophylaxis and treatment of allergic rhinitis and perennial rhinitis and nasal polyps. |
| Caution | Nasal ulceration, dryness, irritation of nose and throat, and epistaxis. Not recommended in children under 2 y ears. |
| Dose Range |
Adults and children over 12 years: 2 sp ray s (55mcg) in each nostril once daily , reducing to 1 sp ray (27.5mcg) once daily once adequate control of symptoms is achieved. Pediatric 2 -12 years: 1 spray in each nostril once daily . See BDS supply pr |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FLUTICASONE |
| Therapeutic Class | ANTI-INFLAMMATORY AGENTS, TOPICAL |
| Indications | Treatment of corticosteroid-responsive derma-toses. |
| Caution | Pruritus, dry skin, numbness of the fingertips, and burning with the cream. Adverse reactions associated with fluticasone ointment include pruritus, burining, hypertrichosis, increased erythema, hives More ... |
| Dose Range | For corticosteroid-responsive dermatoses, apply to the affected area twice daily; for atopic dermatitis, it may be applied once or twice daily. See BDS supply protocols pg. 6. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |